We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
-3.67%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$40.3B
AUM Growth
-$1.82B
Cap. Flow
+$332M
Cap. Flow %
0.83%
Top 10 Hldgs %
25.24%
Holding
2,393
New
237
Increased
785
Reduced
642
Closed
83

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$231M
2
GILD icon
Gilead Sciences
GILD
+$113M
3
PCG icon
PG&E
PCG
+$102M
4
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$80.2M
5
ALL icon
Allstate
ALL
+$64.4M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$472M
2
ABBV icon
AbbVie
ABBV
+$121M
3
VLUE icon
iShares MSCI USA Value Factor ETF
VLUE
+$69.5M
4
CRM icon
Salesforce
CRM
+$64.3M
5
HD icon
Home Depot
HD
+$62.4M

Sector Composition

Rank Sector Weight
1 Technology 20.24%
2 Healthcare 19.03%
3 Financials 13.02%
4 Consumer Discretionary 9.39%
5 Industrials 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOG icon
1776
Northern Oil and Gas
NOG
$2.16B
$256K ﹤0.01%
9,350
+210
+2% +$5.93K
VAL icon
1777
Valaris
VAL
$5.16B
$256K ﹤0.01%
5,230
+2,110
+68% +$101K
AVD icon
1778
American Vanguard Corp
AVD
$74.1M
$255K ﹤0.01%
13,617
LMND icon
1779
Lemonade
LMND
$4.77B
$255K ﹤0.01%
12,030
+3,200
+36% +$72.7K
HSKA
1780
DELISTED
Heska Corp
HSKA
$254K ﹤0.01%
3,480
HLF icon
1781
Herbalife
HLF
$1.3B
$253K ﹤0.01%
12,730
+1,200
+10% +$29.7K
GCO icon
1782
Genesco
GCO
$432M
$252K ﹤0.01%
6,401
TBPH icon
1783
Theravance Biopharma
TBPH
$875M
$252K ﹤0.01%
24,830
ACRS icon
1784
Aclaris Therapeutics
ACRS
$744M
$251K ﹤0.01%
15,950
+4,980
+45% +$78.5K
DDD icon
1785
3D Systems Corp
DDD
$412M
$250K ﹤0.01%
31,383
LOCO icon
1786
El Pollo Loco
LOCO
$497M
$250K ﹤0.01%
28,020
UIS icon
1787
Unisys
UIS
$250M
$249K ﹤0.01%
32,960
WNC icon
1788
Wabash National
WNC
$541M
$249K ﹤0.01%
15,991
TGI
1789
DELISTED
Triumph Group
TGI
$248K ﹤0.01%
28,920
-3,970
-12% -$51.9K
ATNI icon
1790
ATN International
ATNI
$370M
$247K ﹤0.01%
6,408
CYBR
1791
DELISTED
CyberArk
CYBR
$247K ﹤0.01%
1,650
+400
+32% +$57.1K
DLX icon
1792
Deluxe
DLX
$1.25B
$245K ﹤0.01%
14,726
MRTN icon
1793
Marten Transport
MRTN
$1.25B
$245K ﹤0.01%
12,800
CSII
1794
DELISTED
Cardiovascular Systems, Inc.
CSII
$245K ﹤0.01%
17,700
-100
-0.6% -$1.49K
LPSN icon
1795
LivePerson
LPSN
$22.9M
$244K ﹤0.01%
1,729
ELDN icon
1796
Eledon Pharmaceuticals
ELDN
$262M
$241K ﹤0.01%
87,286
+10,186
+13% +$32.4K
BCE icon
1797
BCE
BCE
$20.3B
$240K ﹤0.01%
5,233
-9,100
-63% -$442K
FSLY icon
1798
Fastly Inc
FSLY
$3.26B
$239K ﹤0.01%
26,140
DV icon
1799
DoubleVerify
DV
$1.73B
$238K ﹤0.01%
+8,690
New +$224K
NBHC icon
1800
National Bank Holdings
NBHC
$1.9B
$238K ﹤0.01%
6,440

Similar funds

Ensign Peak Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Ensign Peak Advisors held 2,393 positions worth $40.3B, down 4.3% from $42.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Ensign Peak Advisors's Q3 2022 filing shows 237 new, 785 increased, 642 reduced and 83 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M. The largest sale was Visa, an estimated $472M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q3 2022 buy was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M.
  • Ensign Peak Advisors added most to Mastercard in Q3 2022, an estimated $231M increase.
  • Ensign Peak Advisors's biggest Q3 2022 reduction was AbbVie, cutting an estimated $121M.
  • Ensign Peak Advisors fully exited Visa in Q3 2022, selling an estimated $472M.
  • Ensign Peak Advisors's ten largest holdings make up 25% of its $40.3B portfolio in Q3 2022.
  • Ensign Peak Advisors opened 237 new positions and closed 83 in Q3 2022.
  • Ensign Peak Advisors's portfolio value fell 4.3% quarter-over-quarter to $40.3B.

Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.